| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |